Cervical Ripening Balloon Compared With Vaginal Misoprostol for Cervical Ripening in Obese Woman at Term

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07685756

Enrollment

108

Registered

2026-07-06

Start date

2026-05-01

Completion date

2027-06-01

Last updated

2026-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Ripening

Brief summary

Cervical ripening balloon compared with vaginal misoprostol for cervical ripening in obese woman at term

Interventions

DEVICECervical folleys

We will compare effectiveness of cervical ripening with cervical folleys compared to misoprostol in obese women at term

DRUGMisoprostol

We will compare effectiveness of ripening with misoprostol comoared with cervical folleys in obese women at term

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Caregiver, Investigator)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 40 Years

Healthy volunteers

Inclusion criteria

* obese women bmi \>30, Bishop score \<6 at time of ripening Singleton pregnancy Gestational age more than 37 weeks

Exclusion criteria

* pregnancy with fetal demise congenital anomalies, History of uterine surgery In active labour \>4 cm dialated Obs complication History of uterine hyper stimulation and uterine rupture Feel malpresentation

Design outcomes

Primary

Measure	Time frame	Description
Less rate of instrumental delivery and c section	12 months	Less rate of instrumental delivery and c section in ripening of obese women with cervical folleys as compared to misoprostol at term

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 7, 2026